Literature DB >> 19205992

Level walking and stair climbing gait in above-knee amputees.

T S Bae1, K Choi, M Mun.   

Abstract

To evaluate quantitatively the contribution of each muscle to amputee gait during level walking and stair climbing in transfemoral amputees and healthy individuals, gait analysis and electromyography with transfemoral amputees (n = 8) and healthy adults (n = 10) were performed to evaluate muscle balance during each ambulatory task. Time - distance and kinematic parameters by gait analysis were calculated, and the rms EMG of major muscles and hamstring and tibialis anterior coactivity were measured by electromyography. Most kinematic parameters showed no statistical difference between each task, excluding pelvic tilt, pelvic obliquity and hip abduction. Major muscle activities and coactivities of hamstring and tibialis anterior showed that the stair ascent task needed excessive muscle activity compared with the stair descent task and level walking, and that muscle activity and coactivity of amputees were greater than those of healthy individuals, excluding hamstring coactivity during stair ascent (p < 0.05).

Mesh:

Year:  2009        PMID: 19205992     DOI: 10.1080/03091900701404043

Source DB:  PubMed          Journal:  J Med Eng Technol        ISSN: 0309-1902


  3 in total

1.  Does a microprocessor-controlled prosthetic knee affect stair ascent strategies in persons with transfemoral amputation?

Authors:  Jennifer M Aldridge Whitehead; Erik J Wolf; Charles R Scoville; Jason M Wilken
Journal:  Clin Orthop Relat Res       Date:  2014-10       Impact factor: 4.176

2.  Evaluating Electromyography and Sonomyography Sensor Fusion to Estimate Lower-Limb Kinematics Using Gaussian Process Regression.

Authors:  Kaitlin G Rabe; Nicholas P Fey
Journal:  Front Robot AI       Date:  2022-03-21

3.  Comparison of muscle activity patterns of transfemoral amputees and control subjects during walking.

Authors:  Eva C Wentink; Erik C Prinsen; Johan S Rietman; Peter H Veltink
Journal:  J Neuroeng Rehabil       Date:  2013-08-02       Impact factor: 4.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.